Patents by Inventor Patrick Cornelious MAY

Patrick Cornelious MAY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination Alzheimer therapy using anti-N3pGlu Abeta antibodies + a BACE inhibitor
    Patent number: 9999624
    Abstract: The present invention provides a method of treating a cognitive or neurodegenerative disease, comprising administering to a patient in need of such treatment an effective amount of a compound of the formula I, or a pharmaceutically acceptable salt thereof; in combination with an effective amount of an anti-N3pGlu Abeta monoclonal antibody.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: June 19, 2018
    Assignee: Eli Lilly and Company
    Inventors: Patrick Cornelious May, Dustin James Mergott
  • COMBINATION ALZHEIMER THERAPY USING ANTI-N3PGLU ABETA ANTIBODIES + A BACE INHIBITOR
    Publication number: 20170224702
    Abstract: The present invention provides a method of treating a cognitive or neurodegenerative disease, comprising administering to a patient in need of such treatment an effective amount of a compound of the formula I, or a pharmaceutically acceptable salt thereof; in combination with an effective amount of an anti-N3pGlu Abeta monoclonal antibody.
    Type: Application
    Filed: September 8, 2015
    Publication date: August 10, 2017
    Applicant: Eli Lilly and Company
    Inventors: Patrick Cornelious MAY, Dustin James MERGOTT